Fosun Pharma announces up to HK$1 billion H-share repurchase plan
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. said it intends to repurchase its H-shares with an aggregate amount of up to HK$1 billion.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.